Related Experiment Videos

Clinical and angiographic variables affecting the progression of coronary artery disease as determined by

A Joseph1, J D Talley, A Shih

  • 1Department of Medicine, University of Louisville, KY.

International Journal of Cardiac Imaging
|September 1, 1994
PubMed

Insights

Clinical risk factors do not predict coronary artery disease progression. Beta blocker use and absence of distal disease were linked to less disease progression in coronary segments, as shown by quantitative angiography.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Coronary artery disease (CAD) progression is unpredictable, with controversial roles for clinical risk factors.
  • Previous studies suggest hyperlipidemia intervention may reduce CAD progression.
  • Limited research has explored angiographic features of individual lesions influencing disease advancement.

Purpose of the Study:

  • To evaluate clinical and angiographic variables impacting coronary artery disease progression using serial quantitative angiography.
  • To identify predictors of disease advancement in individual coronary segments.

Main Methods:

  • Analysis of serial angiograms from 74 patients using computer-assisted quantitative angiography.
  • Assessment of 99 diseased segments for progression, defined as a ≥20% absolute reduction in luminal cross-sectional area.
  • Calculation of correlation coefficients and odds ratios for clinical and angiographic variables.

Main Results:

  • Clinical risk factors (diabetes, hypertension, high cholesterol, smoking, family history) did not predict CAD progression.
  • Beta blocker use was associated with a threefold decreased likelihood of progression (odds ratio 0.33).
  • Presence of distal disease correlated with proximal lesion progression (odds ratio 2.4); other lesion characteristics did not influence progression.

Conclusions:

  • Clinical risk factors are not predictive of individual coronary segment disease progression via quantitative angiography.
  • Beta blocker use and absence of coexistent distal disease are associated with reduced progression in coronary segments.
  • Potential mechanisms include altered wall stress, reduced platelet interaction, and improved endothelial function.

Related Concept Videos